Corporate inversions have become a high-profile growth strategy for many life sciences companies. Inversions are not an end in themselves, but should be considered a potential tool for business development and global expansion. Business leaders need to understand how corporate inversions work in order to weigh the costs and benefits of implementation.
In this webinar, WilmerHale lawyers discuss corporate inversions and their value to growing life sciences companies, including: the hallmarks of a successful transaction; regulatory trends and legislative responses to corporate inversions; the effect on shareholder value and business operations; and occasions where an inversion may not be the best strategy.
California and non-transitional New York CLE credit will be offered to those that participate in the live webinar.
